Showing 1 to 2 of 2 results


Metformin Linked to Lower Dementia Risk in Overweight and Obese Individuals
A study of half a million overweight and obese individuals revealed that metformin users had a significantly lower risk of developing dementia and death from any cause, with the greatest benefits observed in those with BMIs between 25 and 34.9.
Metformin Linked to Lower Dementia Risk in Overweight and Obese Individuals
A study of half a million overweight and obese individuals revealed that metformin users had a significantly lower risk of developing dementia and death from any cause, with the greatest benefits observed in those with BMIs between 25 and 34.9.
Progress
40% Bias Score

GLP-1 Drugs Show Promise in Reducing Dementia Risk for Type 2 Diabetes Patients
A study of 174,458 type 2 diabetes patients (2004-2024) found GLP-1 drugs reduced dementia risk by up to 25 percent compared to metformin, also lowering overall death rates; further research is needed.

GLP-1 Drugs Show Promise in Reducing Dementia Risk for Type 2 Diabetes Patients
A study of 174,458 type 2 diabetes patients (2004-2024) found GLP-1 drugs reduced dementia risk by up to 25 percent compared to metformin, also lowering overall death rates; further research is needed.
Progress
56% Bias Score
Showing 1 to 2 of 2 results